Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients

Derek Culnan, Karel D. Capek, Charles Voigt, Kuzhali Muthumalaiappan

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Severely burned patients suffer significant hematologic pathologies. Anemia develops from burn excisions and the anemia of critical illness. Fluid shifts, resuscitation, and factor consumption can cause significant coagulopathy. Transfusion of red blood cells to treat anemia, plasma to treat coagulopathy, and other blood products are critical to burn management. Critical illness, injury, immobilization, and other factors create a hypercoagulable state requiring venothromboembolic prophylaxis. Hematopoietic changes reduce red blood cell generation as well as affecting downstream immunologic function. Facile management of these hematologic pathologies is essential to the medical and surgical management of burn patients.

Original languageEnglish (US)
Title of host publicationTotal Burn Care
Subtitle of host publicationFifth Edition
PublisherElsevier Inc.
Pages236-247.e6
ISBN (Electronic)9780323497428
ISBN (Print)9780323476614
DOIs
StatePublished - Jan 1 2018

Keywords

  • Anemia
  • Anticoagulation
  • Coagulation
  • Hematopoiesis
  • Hemostasis
  • Heparin
  • Stem cells
  • Thromboelastogram/TEG
  • Transfusion
  • VTE

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients'. Together they form a unique fingerprint.

  • Cite this

    Culnan, D., Capek, K. D., Voigt, C., & Muthumalaiappan, K. (2018). Hematology, hemostasis, thromboprophylaxis, and transfusion medicine in burn patients. In Total Burn Care: Fifth Edition (pp. 236-247.e6). Elsevier Inc.. https://doi.org/10.1016/B978-0-323-47661-4.00022-8